当前查询到30条专利与查询词 "【中文】金华市中心医院"相关,搜索用时1.5937437秒!排序方式:
发明专利:3实用新型: 27外观设计: 0
3 条,当前第 1-3 条 返回搜索页
申请号:201911389840.0 公开号:CN110975131A 主分类号:A61M35/00
申请人:【中文】金华市中心医院【EN】JINHUA MUNICIPAL CENTRAL Hospital 申请日:2019.12.30 公开日:2020.04.10
摘要:【中文】针筒式一次性穴位贴制作仪,包括针筒、拆分式推杆和针筒盖,拆分式推杆滑动安装在针筒内,拆分式推杆可以用于对中药进行搅拌,也可以用于将中药推出针筒外,针筒盖可拆式安装在针筒的端部,在针筒盖内设有通孔,拆分式推杆通过通孔伸出于针筒外侧,在针筒盖的侧壁上固定连接有支撑架,通过支撑架的设置,可以将针筒盖直立防止在平面上,防止针筒盖被污染。 【EN】The disposable acupuncture point of cylinder formula pastes preparation appearance, including the cylinder, split formula push rod and cylinder lid, split formula push rod slidable mounting is in the cylinder, split formula push rod can be used for stirring traditional chinese medicine, also can be used for pushing away traditional chinese medicine outside the cylinder, the removable tip of installing at the cylinder of cylinder lid, be equipped with the through-hole in the cylinder lid, split formula push rod stretches out in the cylinder outside through the through-hole, fixedly connected with support frame on the lateral wall of cylinder lid, through the setting of support frame, can prevent vertically on the plane with the cylinder lid, prevent that the cylinder lid from being contaminated by the lid.
详细信息 下载全文

申请号:202010070114.9 公开号:CN111184812A 主分类号:A61K36/8969
申请人:【中文】金华市中心医院【EN】JINHUA MUNICIPAL CENTRAL Hospital 申请日:2020.01.21 公开日:2020.05.22
摘要:【中文】本发明属于医药制剂领域,具体涉及一种复方草石蚕颗粒慢性阻塞性肺疾病治疗药物制剂中的应用,复方草石蚕颗粒配方为:黄芪、红参、玉竹、草石蚕。在服用本发明的复方草石蚕颗粒后可降低促炎因子并增加抑炎因子,减少诱发AE概率;可减少患者的SGRQ评分,改善患者生活质量,临床实验证明草石蚕组较安慰剂组减少AE的发生率达47.9%。 【EN】The invention belongs to the field of pharmaceutical preparations, and particularly relates to an application of compound Chinese artichoke granules in a pharmaceutical preparation for treating chronic obstructive pulmonary disease, wherein the formula of the compound Chinese artichoke granules is as follows: astragalus root, red ginseng, fragrant solomonseal rhizome, Chinese artichoke. After the compound Chinese artichoke granules are taken, the proinflammatory factors can be reduced, the inflammation inhibiting factors can be increased, and the AE induction probability can be reduced; the SGRQ score of a patient can be reduced, the life quality of the patient is improved, and clinical experiments prove that the incidence rate of AE reduction of the stachys sieboldii group is 47.9% compared with that of a placebo group.
详细信息 下载全文

申请号:201911352399.9 公开号:CN111091564A 主分类号:G06T7/00
摘要:【中文】本发明提供了一种基于3DUnet的肺结节大小检测系统,包括肺叶分割模块和病灶检测模块;所述肺叶分割模块被配置为读取肺部CT图像、去除肺部CT图像中的无关区域和输出肺部分割图像;所述病灶检测模块被配置为读取所述肺部分割图像、定位病灶、输出特征图和输出定位结果。这种基于3DUnet的肺结节大小检测系统能够准确通过特征图和定位结果给出肺结节概率、肺结节中心点和肺结节大小信息。 【EN】The invention provides a pulmonary nodule size detection system based on 3DUnet, which comprises a lung lobe segmentation module and a focus detection module; the lung lobe segmentation module is configured to read a lung CT image, remove irrelevant areas in the lung CT image and output a lung segmentation image; the lesion detection module is configured to read the lung segmentation image, locate a lesion, output a feature map, and output a location result. The lung nodule size detection system based on the 3DUnet can accurately give the lung nodule probability, the lung nodule central point and the lung nodule size information through the feature map and the positioning result.
详细信息 下载全文

3 条,当前第 1-3 条 返回搜索页